PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 56 filers reported holding PROFOUND MED CORP in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,860,612 | -19.8% | 182,413 | +2.3% | 0.00% | – |
| Q2 2023 | $2,320,230 | +40.7% | 178,342 | +0.5% | 0.00% | – |
| Q1 2023 | $1,649,347 | -15.6% | 177,540 | -1.0% | 0.00% | – |
| Q4 2022 | $1,953,372 | +175.1% | 179,373 | +2.1% | 0.00% | – |
| Q3 2022 | $710,000 | +25.7% | 175,600 | +126.6% | 0.00% | – |
| Q2 2022 | $565,000 | -20.0% | 77,500 | -1.1% | 0.00% | – |
| Q1 2022 | $706,000 | -16.4% | 78,378 | +4.2% | 0.00% | – |
| Q4 2021 | $844,000 | -33.9% | 75,186 | -13.8% | 0.00% | – |
| Q3 2021 | $1,277,000 | +55.5% | 87,228 | +73.8% | 0.00% | – |
| Q2 2021 | $821,000 | -33.5% | 50,186 | -18.1% | 0.00% | – |
| Q1 2021 | $1,234,000 | +13.2% | 61,271 | +15.6% | 0.00% | – |
| Q4 2020 | $1,090,000 | -5.5% | 52,997 | -19.0% | 0.00% | – |
| Q3 2020 | $1,154,000 | +69.0% | 65,404 | +62.3% | 0.00% | – |
| Q2 2020 | $683,000 | +103.9% | 40,286 | +17.2% | 0.00% | – |
| Q1 2020 | $335,000 | +487.7% | 34,386 | +558.4% | 0.00% | – |
| Q4 2019 | $57,000 | – | 5,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 341,767 | $7,029,000 | 13.80% |
| GAGNON SECURITIES LLC | 821,196 | $16,883,000 | 2.69% |
| Gagnon Advisors, LLC | 277,252 | $5,700,000 | 2.56% |
| Taylor Wealth Management Partners | 166,294 | $3,419,000 | 1.32% |
| PCJ Investment Counsel Ltd. | 126,930 | $2,611,000 | 1.22% |
| EAM Global Investors LLC | 172,291 | $3,542,000 | 0.96% |
| AWM Investment Company, Inc. | 348,939 | $7,174,000 | 0.91% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $16,048,000 | 0.58% |
| Wealth Management Partners, LLC | 20,282 | $554,000 | 0.43% |
| Parkman Healthcare Partners LLC | 69,049 | $1,420,000 | 0.36% |